Lisa Ford

3.2k total citations
41 papers, 1.1k citations indexed

About

Lisa Ford is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lisa Ford has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 17 papers in Pediatrics, Perinatology and Child Health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lisa Ford's work include Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Schizophrenia research and treatment (6 papers). Lisa Ford is often cited by papers focused on Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Schizophrenia research and treatment (6 papers). Lisa Ford collaborates with scholars based in United States, Belgium and United Kingdom. Lisa Ford's co-authors include Mariëlle Eerdekens, Michelle Kramer, Pilar Lim, Robin Emsley, Michael Davidson, Andrew B. Norman, Guohua Pan, Stephen R. Marder, Adam Lowy and Seth Ness and has published in prestigious journals such as PEDIATRICS, Biological Psychiatry and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Lisa Ford

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Ford United States 16 693 188 151 117 101 41 1.1k
Claudia Mehler‐Wex Germany 21 609 0.9× 237 1.3× 111 0.7× 93 0.8× 67 0.7× 50 1.1k
W. W. Fleischhacker Austria 19 861 1.2× 141 0.8× 117 0.8× 147 1.3× 160 1.6× 53 1.5k
Cristiana Gassmann-Mayer United States 16 1.2k 1.7× 318 1.7× 126 0.8× 67 0.6× 173 1.7× 16 1.6k
C. Barnas Austria 19 700 1.0× 109 0.6× 166 1.1× 65 0.6× 197 2.0× 61 1.2k
Riccardo Torta Italy 24 559 0.8× 264 1.4× 115 0.8× 73 0.6× 270 2.7× 74 1.7k
Christoph Born Germany 24 511 0.7× 107 0.6× 47 0.3× 92 0.8× 131 1.3× 49 1.2k
Ludmila Kryzhanovskaya United States 17 830 1.2× 149 0.8× 149 1.0× 100 0.9× 87 0.9× 29 1.1k
Judith C. Kando United States 15 741 1.1× 199 1.1× 99 0.7× 53 0.5× 264 2.6× 40 1.2k
Frank Theisen Germany 21 739 1.1× 126 0.7× 135 0.9× 293 2.5× 107 1.1× 35 1.3k
Subramoniam Madhusoodanan United States 21 779 1.1× 97 0.5× 95 0.6× 60 0.5× 220 2.2× 62 1.5k

Countries citing papers authored by Lisa Ford

Since Specialization
Citations

This map shows the geographic impact of Lisa Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Ford more than expected).

Fields of papers citing papers by Lisa Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Ford. The network helps show where Lisa Ford may publish in the future.

Co-authorship network of co-authors of Lisa Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Ford. A scholar is included among the top collaborators of Lisa Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Ford. Lisa Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nasr, Suhayl, Karu Jayathilake, Stefanie Rassnick, et al.. (2024). Lack of Efficacy of JNJ-18038683 on Cognitive Impairment in Patients With Stable Bipolar Disorder. Journal of Clinical Psychopharmacology. 44(5). 481–491.
3.
Davidson, Michael, Linda Levi, Jin‐Young Park, et al.. (2021). The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial. European Neuropsychopharmacology. 51. 33–42. 13 indexed citations
4.
Edwards, Charles C., et al.. (2017). Deep Vein Thrombosis After Complex Posterior Spine Surgery: Does Staged Surgery Make a Difference?. Spine Deformity. 6(2). 141–147. 9 indexed citations
5.
Ford, Lisa, et al.. (2017). Comprehensive review of visual defects reported with topiramate. Clinical ophthalmology. Volume 11. 983–992. 2 indexed citations
6.
Perkins, Kenneth A., K. N. Roy Chengappa, Joshua L. Karelitz, et al.. (2017). Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia. Neuropsychopharmacology. 43(6). 1334–1342. 14 indexed citations
7.
Goldberg, Jeffrey L., et al.. (2016). Is uveitis associated with topiramate use? A cumulative review. Clinical ophthalmology. Volume 10. 1467–1470. 6 indexed citations
8.
Manitpisitkul, Prasarn, Christopher R. Curtin, Kevin Shalayda, et al.. (2014). Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment. Epilepsy Research. 108(5). 891–901. 20 indexed citations
9.
Prospero, Nicholas A. Di, Gahan Pandina, Lisa Ford, et al.. (2014). Evaluation of JNJ-26489112 in patients with photosensitive epilepsy: A placebo-controlled, exploratory study. Epilepsy Research. 108(4). 709–716. 7 indexed citations
10.
Ford, Lisa, et al.. (2013). Effect of Topiramate Monotherapy on Height in Newly Diagnosed Children With Epilepsy. Pediatric Neurology. 48(5). 383–389. 5 indexed citations
11.
Manitpisitkul, Prasarn, Christopher R. Curtin, Kevin Shalayda, et al.. (2013). An Open-Label Drug–Drug Interaction Study of the Steady-State Pharmacokinetics of Topiramate and Glyburide in Patients with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 33(12). 929–938. 2 indexed citations
12.
13.
Ness, Seth, et al.. (2012). Adaptive Behavior Outcomes in Infants Treated With Adjunctive Topiramate. Pediatric Neurology. 46(6). 350–358. 6 indexed citations
14.
Pandina, Gahan, Seth Ness, Elena Polverejan, et al.. (2010). Cognitive Effects of Topiramate in Migraine Patients Aged 12 Through 17 Years. Pediatric Neurology. 42(3). 187–195. 25 indexed citations
15.
16.
Davidson, Michael, Robin Emsley, Michelle Kramer, et al.. (2007). Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study. Schizophrenia Research. 93(1-3). 117–130. 203 indexed citations
17.
Norman, Andrew B., et al.. (1991). Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum. Experimental Neurology. 114(1). 132–135. 19 indexed citations
18.
Giòrdano, Magda, Lisa Ford, Michael T. Shipley, & Paul R. Sanberg. (1990). Neural grafts and pharmacological intervention in a model of Huntington's disease. Brain Research Bulletin. 25(3). 453–465. 22 indexed citations
19.
Ford, Lisa, Andrew B. Norman, & Paul R. Sanberg. (1989). The topography of MK-801-induced locomotor patterns in rats. Physiology & Behavior. 46(4). 755–758. 48 indexed citations
20.
Ford, Lisa. (1989). Neurologic Status and Intracranial Hemorrhage in Very-Low-Birth-Weight Preterm Infants. American journal of diseases of children. 143(10). 1186–1186. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Mehler‐Wex Breakdown of academic impact, for papers by W. W. Fleischhacker Breakdown of academic impact, for papers by Cristiana Gassmann-Mayer Breakdown of academic impact, for papers by C. Barnas Breakdown of academic impact, for papers by Riccardo Torta Breakdown of academic impact, for papers by Christoph Born Breakdown of academic impact, for papers by Ludmila Kryzhanovskaya Breakdown of academic impact, for papers by Judith C. Kando Breakdown of academic impact, for papers by Frank Theisen Breakdown of academic impact, for papers by Subramoniam Madhusoodanan
Rankless by CCL
2026